Our study demonstrates that miR-544a regulates invasive and metastatic properties of CRC cells by modulating HOXA10 expression level both in vitro and in vivo. miR-544a may represent a new therapeutic target for the intervention of metastatic colorectal cancer.
Aim: To examine the expression status of long-noncoding RNA LINC00265 and mechanistically elucidate its involvements in colorectal cancer (CRC). Methods: Relative abundances of LINC00265, miR-216b-5p, and tripartite-motif (TRIM)44 transcript were determined with real-time polymerase chain reaction. Cell viability was measured with cell counting kit-8 kit. Glucose uptake, pyruvate, and lactate production were quantified with commercially available kits. The potential regulatory effects of miR-216b-5p on both LINC00265 and TRIM44 were interrogated by luciferase reporter assay. The direct association between miR-216b-5p with both LINC00265 and TRIM44 was analyzed with pulldown assay. The TRIM44 protein was quantitated by western blotting. Results: LINC00265 was upregulated in CRC both in vivo and in vitro, which intimately associated with poorer prognosis. LINC00265-deficiency resulted into decreases in cell viability, glucose uptake, pyruvate production, and lactate production. Mechanistically, LINC00265 directly bound to miR-216b-5p and negatively regulated miR-216b-5p. Consequently, the suppression on TRIM44 expression was released. Supplementation with ectopic miR-216b-5p significantly compromised the oncogenic activities of LINC00265 in CRC cells. Conclusion: Our study highlighted the contribution of LINC00265/miR-216b-5p/TRIM44 signaling axis in CRC.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.